Joan Lo to Femoral Fractures
This is a "connection" page, showing publications Joan Lo has written about Femoral Fractures.
Connection Strength
3.244
-
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
Score: 0.742
-
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
Score: 0.683
-
The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
Score: 0.528
-
Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014 Sep; 25(9):2313-8.
Score: 0.475
-
Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012 Sep; 51(3):524-7.
Score: 0.411
-
Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
Score: 0.405